Return-path: <response@response.hansonwade.com>
Envelope-to: amber@transocean.com
Delivery-date: Thu, 26 May 2016 07:04:14 -0700
Received: from e215.en25.com ([209.167.231.215]:60765)
	by vps.transocean.com with esmtp (Exim 4.86_1)
	(envelope-from <response@response.hansonwade.com>)
	id 1b5vtR-0008Sy-AF
	for amber@transocean.com; Thu, 26 May 2016 07:04:13 -0700
Received: from [10.4.1.245] ([10.4.1.245:45993] helo=P01SNJ029)
	by msm-mta05-tor6 (envelope-from <response@response.hansonwade.com>)
	(ecelerity 3.6.9.48312 r(Core:3.6.9.0)) with ESMTP
	id 3F/D5-01010-B2207475; Thu, 26 May 2016 10:03:23 -0400
Message-ID: <59b585e9b24f48f580f8a6a5661fd38f@2622>
X-Binding: 2622
X-elqSiteID: 2622
X-elqPod: 0x04D4AA276AEFAC548AF4C2541180280C6E4E16410A533B620AAC2EC8FC2601D8
List-Unsubscribe: <http://s2622.t.en25.com/e/u?s=2622&elq=59b585e9-b24f-48f5-80f8-a6a5661fd38f>
MIME-Version: 1.0
From: "Farrah Ali" <info@hansonwade.com>
To: amber@transocean.com
Reply-To: "Hanson Wade" <info@hansonwade.com>
Date: 26 May 2016 10:03:11 -0400
Subject: Find the True Meaning in your Data & RWE: Advanced Pharma Analytics
 Summit 2016
Content-Type: multipart/alternative;
 boundary=--boundary_3915795_58c70ac1-45d7-4604-9bf7-d8037ad64a78
X-Spam-Status: No, score=3.5
X-Spam-Score: 35
X-Spam-Bar: +++
X-Ham-Report: Spam detection software, running on the system "vps.transocean.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  Dear Alison, Capitalize on Advanced Data Analytics Best Practice
    to Improve Patient-Centric Outcomes With the avalanche of data upon us, drug
    developers strive to extract more meaningful insight, value and outcomes
   from their advanced data analytics and RWE to improve decision making. [...]
    
 
 Content analysis details:   (3.5 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.0 RCVD_IN_DNSWL_NONE     RBL: Sender listed at http://www.dnswl.org/, no
                             trust
                             [209.167.231.215 listed in list.dnswl.org]
 -0.0 RCVD_IN_MSPIKE_H3      RBL: Good reputation (+3)
                             [209.167.231.215 listed in wl.mailspike.net]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
  1.0 HTML_FONT_FACE_BAD     BODY: HTML font face is not a word
  0.8 BAYES_50               BODY: Bayes spam probability is 40 to 60%
                             [score: 0.5000]
  1.0 URIBL_GREY             Contains an URL listed in the URIBL greylist
                             [URIs: en25.com]
  0.5 URIBL_GOLD             Contains an URL listed in the URIBL GOLDlist
                             [URIs: en25.com]
 -0.0 RCVD_IN_MSPIKE_WL      Mailspike good senders
  0.2 KAM_LOTSOFHASH         Emails with lots of hash-like gibberish
X-Spam-Flag: NO


----boundary_3915795_58c70ac1-45d7-4604-9bf7-d8037ad64a78
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: base64
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----boundary_3915795_58c70ac1-45d7-4604-9bf7-d8037ad64a78
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit

<!DOCTYPE html>
<html>
<head>
<!-- StartSystemHeader --><style>body{   } a img{border: none;}.ReadMsgBody { width: 100%;}.ExternalClass {width: 100%;}</style><!-- EndSystemheader --></head>
<body style=""><table align="left" width="7" height="3">
<tbody>
<tr>
<td align="centre"><br></td></tr></tbody></table><br>
 <table width="100%" border="0" cellspacing="0" cellpadding="0" class="email-body-wrapper"><tr><td align="center" height="0"></td></tr><tr><td>
<table cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" width="600" align="left" id="sc3343" style="table-layout: auto; empty-cells: show"><tr><td valign="top" align="left" rowspan="1" colspan="2" width="600" id="view0" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc3435" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 0px; width: 600px; top: 0px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word"><div class="co-border-style" style="">

<table width="600" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute"><div><span style="letter-spacing:0px;">Dear Alison,</span><br></div><div><br></div><div style="text-align:center;">
<b>Capitalize on Advanced Data Analytics Best Practice to Improve Patient-Centric Outcomes</b></div><div><br></div><div>With
 the avalanche of data upon us, drug developers strive to extract more meaningful insight, value and outcomes from their advanced data analytics and RWE to improve decision making.</div><div><br></div><div>As such, the <b><i>
<a href="http://www.advancedpharma-analytics.com/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=9D3541556B095C6E757D70B1D22A548C&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" data-targettype="webpage">4th Annual Advanced Pharma Analytics Summit 2016</a></i></b> (formerly know as Big Data in Pharma) in <b>Morristown, New Jersey</b>
 (Sept 20-22) remains dedicated to helping commercial departments within pharma and biotech improve patient-centric decision making through the application of data science, predictive analytics and advanced big data solutions.</div><div><br></div><div>Fuelled

 by real-world case studies, discover how to extract maximum value, insight and tangible outcomes from your data to make quicker and better decisions within your business, which optimize health economics, market access, pricing & reimbursement strategies.</div><div><br></div><div><b>
<a href="http://www.advancedpharma-analytics.com/about/full-event-guide/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=13344AF7B294D6213A5341C3BC377482&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" data-targettype="webpage">Download the newly published Event Guide</a></b> for the first look at the agenda and unrivalled speaker line up.</div><div><br></div><div>Below is a snapshot of the <b>industry defining speakers</b>
 who will be <b>delivering 15+ case studies</b>:</div><div><ul><li><span style="letter-spacing:0px;"><b>Ryan Copping</b>, Global Head, Real World Data Science (RWDS) Analytics, <b>Genentech</b></span><br></li><li><span style="letter-spacing:0px;"><b>William Capra</b>,
 Senior Director, Global Head of Real World Data-Science Oncology, <b>Genentech</b></span><br></li><li><span style="letter-spacing:0px;"><b>James Harnett</b>, Senior Director, Real World Evidence and Analytics, <b>Pfizer&nbsp;</b></span>
<br></li><li><span style="letter-spacing:0px;"><b>Tehseen Salimi</b>, Vice President, Global Medical Affairs, <b>Takeda&nbsp;</b></span><br></li><li><span style="letter-spacing:0px;"><b>Shri Kulkarni</b>, IT Service Manager, Consumer Healthcare IT, Commercial Operations & Analytics, <b>GSK</b></span><br></li><li><span style="letter-spacing:0px;"><b>Dalia Mahmoud</b>, Head of Global Pricing, Market Access Hematology & Oncology, <b>Celgene&nbsp;</b></span><br></li><li><span style="letter-spacing:0px;"><b>Todd
 Townsend</b>, Commissioner's Fellow, <b>FDA</b></span><br></li><li><span style="letter-spacing:0px;"><b>Larry Pickett,</b>
 Vice President & Chief Information Officer, <b>Purdue Pharma</b></span><br></li><li><span style="letter-spacing:0px;"><b>Nataraj Dasgupta</b>, Senior Lead Data Scientist, <b>Purdue Pharma&nbsp;</b></span><br></li><li><span style="letter-spacing:0px;"><b>Kitty Rajagopalan</b>, Vice President & Head, Health Economics & Outcomes Research, <b>Sunovion Pharmaceuticals</b></span><br>
</li></ul></div><div><b><a href="http://www.advancedpharma-analytics.com/about/full-event-guide/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=5D22956E3263DB6C10B3D9FEB85EC966&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" data-targettype="webpage">Download the Event Guide</a></b> for the full speaker line-up.</div><div><br></div><div>Below are a mere 5 <b>key case studies</b>
 you can discover at the Advanced Pharma Analytics Summit 2016:</div><div><ul><li><span style="letter-spacing:0px;">Study the internal infrastructures <b style="color:rgb(224, 25, 41);">Genentech</b>
 has developed to facilitate the incorporation of real-world evidence across the entire product lifecycle&nbsp;</span><br></li><li><span style="letter-spacing:0px;">Learn how <b style="color:rgb(224, 25, 41);">Celgene</b>
 is utilizing data from deploy sensors and devices to support post-approval patient outcomes research&nbsp;</span><br></li><li><span style="letter-spacing:0px;">Learn how the <b style="color:rgb(224, 25, 41);">FDA</b> is working with pharma to develop industry-wide standardized endpoints for real-world evidence&nbsp;</span><br></li><li><span style="letter-spacing:0px;">Explore how real-world evidence is being harnessed by <b style="color:rgb(224, 25, 41);">Eisai</b>
 to increase market access and to develop economic models for optimized value-based pricing strategies&nbsp;</span><br></li><li><span style="letter-spacing:0px;">Discover
 how <b style="color:rgb(224, 25, 41);">GSK</b> is utilizing data from electronic channels to improve physician and patient engagement for optimized market access</span><br></li></ul></div><div><b>
<a href="http://www.advancedpharma-analytics.com/about/full-event-guide/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=FC7E6B733AC1E70299B08C5AA1CB6187&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" data-targettype="webpage">Download the Event Guide</a></b> to see the full agenda.</div><div><br></div><div>If you have any questions or enquiries, please get in touch.</div><div><br></div><div>Kind regards,</div><div>Farrah</div><div>
<br></div><div>P.s. <b><a href="http://www.advancedpharma-analytics.com/register-2/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=9F7AA88D40AD738726D91FD284B3FADC&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" data-targettype="webpage">Register now</a></b> to save up to $400.&nbsp;</div><div><br></div><div><b>Farrah Ali Ph.D</b></div><div><b>Senior Program Director</b></div><div><b>Hanson Wade</b></div></span></td></tr></table>

</div></div></td></tr><tr><td align="left" valign="top" width="284" height="9" id="empty2" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="316" id="empty3" style="font-size: 1px">&nbsp;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" width="284" id="view4" style=""><div id="sc3443" class="sc-view" style="left: 0px; width: 284px; top: 1047px; height: 81px"><div class="co-border-style" style="border-width: 2px; border-style: none">
<table width="284" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able">
<a href="http://www.advancedpharma-analytics.com/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elqTrackId=E222EF3B441D4C59B639FC6F38BCB366&elq=59b585e9b24f48f580f8a6a5661fd38f&elqaid=12321&elqat=1&elqCampaignId=10832" title="">
<img elqhref="http://www.advancedpharma-analytics.com/?elqTrackId=E222EF3B441D4C59B639FC6F38BCB366" elqtitle="" data-targettype="webpage" width="284" height="81" src="http://img.en25.com/EloquaImages/clients/HansonWadeLtd/%7b3d2a76ce-e647-4995-8ef5-850c7d0c0135%7d_7920_Advanced_Pharma_Analytics_US_2016_logo_v2.jpg" title="" alt="" id="sc3445" class="sc-view sc-image-view editor-outline sc-regular-size" style="display: block; cursor: pointer"></a></td></tr></table></div></div></td>
<td align="left" valign="top" width="316" id="empty5" style="font-size: 1px">&nbsp;</td></tr><tr><td align="left" valign="top" width="284" height="72" id="empty6" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="316" id="empty7" style="font-size: 1px">&nbsp;</td></tr></table></td></tr><tr><td align="center" height="0"></td></tr></table> 
<font style="font-family: Arial; font-size: 10px;" face="">If
 you no longer wish to receive updates about this meeting <a title="Stop receiving emails about this meeting" href="http://s2622.t.en25.com/e/cu?s=2622&elqc=420&elq=59b585e9b24f48f580f8a6a5661fd38f">click here</a></font><br><font style="font-family: Arial; font-size: 10px;" face="">To unsubscribe from all further email communication from Hanson Wade <a title="Opt out of all Hanson Wade email communication" href="http://s2622.t.en25.com/e/u?s=2622&elq=59b585e9b24f48f580f8a6a5661fd38f">click here</a>.
 </font><br><font style="font-family: Arial; font-size: 10px;" face="">This email was sent to you at: </font><font style="font-family: Arial; font-size: 10px;" face="">amber@transocean.com</font><br><font style="font-family: Arial; font-size: 10px;" face=""><a title="Hanson Wade" href="http://www.hansonwade.com/?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elq=59b585e9b24f48f580f8a6a5661fd38f&elqCampaignId=10832">Hanson Wade</a>
 respects your <a title="Privacy Policy" href="http://hansonwade.com/privacy?utm_campaign=APA-6503-INT-EM2-LaunchROTW&utm_medium=email&utm_source=Eloqua&elq=59b585e9b24f48f580f8a6a5661fd38f&elqCampaignId=10832">privacy</a></font><br><font style="font-family: Arial; font-size: 10px;">&copy; 2012, Hanson Wade, 52 Grosvenor Gardens, London, SW1W 0AU</font>

<img src='http://s2622.t.en25.com/e/FooterImages/FooterImage1?elq=59b585e9b24f48f580f8a6a5661fd38f&siteid=2622' alt="" border=0 width=1px height=1px>
</body></html>
----boundary_3915795_58c70ac1-45d7-4604-9bf7-d8037ad64a78--


